• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸盐:新的胆固醇?磷酸盐轴在非尿毒症性血管疾病中的作用。

Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease.

机构信息

Department of Cardiovascular Science, Sheffield University, Medical School, Beech Hill Road, Sheffield S10 2RX, United Kingdom.

出版信息

Atherosclerosis. 2012 Feb;220(2):310-8. doi: 10.1016/j.atherosclerosis.2011.09.002. Epub 2011 Sep 9.

DOI:10.1016/j.atherosclerosis.2011.09.002
PMID:21962238
Abstract

Higher serum phosphate levels within the normal range are associated with substantially increased risk of cardiovascular disease events. Whether this reflects a causative relationship is unknown. Phosphate-responsive hormones (fibroblast growth factor-23, parathyroid hormone and calcitriol) are also predictors of cardiovascular mortality in populations without kidney disease or recognised disturbances of bone mineral metabolism. The high bioavailable phosphate content of Western diets may contribute to this apparent discrepancy between 'normal' and optimal phosphate axis parameters. Although uremic hyperphosphatemia is recognised to cause vascular medial calcification, this does not readily explain the association of higher-normal phosphate with common athero-occlusive phenomena. The phosphate axis may in fact play a role in atherogenesis; observational data link higher levels of phosphate and fibroblast growth factor-23 with coronary atheroma burden, whilst dietary phosphate supplementation accelerates atherosclerosis in a mouse model. In vitro studies show adverse effects of phosphate increases on both vascular smooth muscle cells and endothelium, though these observations have not yet been extended to phosphate increments within the normal range. Receptors for phosphate-responsive hormones are present throughout the cardiovascular system and may mediate atherogenic effects. Since interventions are already available to manipulate the phosphate axis, this is an important issue. If an atherogenic role for phosphate exposure is demonstrated then phosphate binders could become the new statins.

摘要

血清磷酸盐水平在正常范围内升高与心血管疾病事件的风险显著增加有关。目前尚不清楚这是否反映了因果关系。在没有肾脏疾病或已知骨矿物质代谢紊乱的人群中,磷酸盐反应激素(成纤维细胞生长因子 23、甲状旁腺激素和 1,25-二羟维生素 D3)也是心血管死亡率的预测因子。西方饮食中高生物可利用的磷酸盐含量可能导致“正常”和最佳磷酸盐轴参数之间出现这种明显差异。尽管尿毒症高磷血症可导致血管中层钙化,但这并不能很好地解释较高正常磷酸盐与常见动脉粥样硬化闭塞现象的关联。磷酸盐轴实际上可能在动脉粥样硬化形成中起作用;观察性数据表明,较高的磷酸盐和成纤维细胞生长因子 23 水平与冠状动脉粥样斑块负担有关,而饮食磷酸盐补充加速了小鼠模型中的动脉粥样硬化。体外研究表明,磷酸盐增加对血管平滑肌细胞和内皮均有不良影响,但这些观察结果尚未扩展到正常范围内的磷酸盐增加。磷酸盐反应激素的受体存在于整个心血管系统中,可能介导动脉粥样硬化形成的作用。由于已经有干预措施来操纵磷酸盐轴,因此这是一个重要问题。如果磷酸盐暴露具有动脉粥样硬化作用,那么磷酸盐结合剂可能成为新的他汀类药物。

相似文献

1
Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease.磷酸盐:新的胆固醇?磷酸盐轴在非尿毒症性血管疾病中的作用。
Atherosclerosis. 2012 Feb;220(2):310-8. doi: 10.1016/j.atherosclerosis.2011.09.002. Epub 2011 Sep 9.
2
Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management.肾衰竭中的高磷血症:病理生理学、挑战及磷管理的关键作用
Nutrients. 2025 May 5;17(9):1587. doi: 10.3390/nu17091587.
3
Osteo-renal regulation of systemic phosphate metabolism.骨肾对全身磷代谢的调节。
IUBMB Life. 2011 Apr;63(4):240-7. doi: 10.1002/iub.437. Epub 2011 Mar 24.
4
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.磷酸盐喂养诱导尿毒症小鼠动脉中层钙化:血清磷、成纤维细胞生长因子-23和骨桥蛋白的作用。
Kidney Int. 2009 Jun;75(12):1297-1307. doi: 10.1038/ki.2009.83. Epub 2009 Mar 25.
5
[Novel hormones related to the calcium and phosphate homeostasis in kidney disease].[与肾脏疾病中钙磷稳态相关的新型激素]
Ugeskr Laeger. 2018 May 21;180(21).
6
Phosphate: a stealthier killer than previously thought?磷酸盐:比想象中更阴险的杀手?
Cardiovasc Pathol. 2012 Sep-Oct;21(5):372-81. doi: 10.1016/j.carpath.2012.02.008. Epub 2012 Mar 16.
7
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
8
Phosphate is a vascular toxin.磷是一种血管毒素。
Pediatr Nephrol. 2013 Apr;28(4):583-93. doi: 10.1007/s00467-012-2347-x. Epub 2012 Nov 17.
9
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure.肾衰竭患者高磷血症药物治疗的进展
Expert Opin Pharmacother. 2023 Sep-Dec;24(15):1737-1746. doi: 10.1080/14656566.2023.2243817. Epub 2023 Aug 11.
10
Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.骨形态发生蛋白-7在肾脏骨中的作用及效应与慢性肾脏病中的骨-血管联系
Eur J Clin Invest. 2006 Aug;36 Suppl 2:43-50. doi: 10.1111/j.1365-2362.2006.01663.x.

引用本文的文献

1
The true cost of phosphate control in chronic kidney disease.慢性肾脏病中磷酸盐控制的真实成本。
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i46-i60. doi: 10.1093/ckj/sfae434. eCollection 2025 Mar.
2
Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure.使用成纤维细胞生长因子-23(FGF-23)和可溶性α-klotho对急性心力衰竭患者进行风险分层
J Clin Med. 2025 Jan 28;14(3):860. doi: 10.3390/jcm14030860.
3
The effects of fibroblast growth factor-23 on diagnosis of cerebral infarction and vertebral basilar artery stenosis.
成纤维细胞生长因子 23 对脑梗死和椎基底动脉狭窄诊断的影响。
Clinics (Sao Paulo). 2024 Aug 2;79:100457. doi: 10.1016/j.clinsp.2024.100457. eCollection 2024.
4
The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review.他汀类药物对血管钙化的复杂机制及潜在影响:一项叙述性综述
Rev Cardiovasc Med. 2024 Jan 30;25(2):51. doi: 10.31083/j.rcm2502051. eCollection 2024 Feb.
5
Association of Circulating Endothelial Nitric Oxide Synthase Levels with Phosphataemia in Patients on Haemodialysis.血液透析患者循环内皮型一氧化氮合酶水平与血磷的关系
Biomedicines. 2024 Mar 19;12(3):687. doi: 10.3390/biomedicines12030687.
6
Biological Activity and Structural Diversity of Steroids Containing Aromatic Rings, Phosphate Groups, or Halogen Atoms.含芳环、磷酸基团或卤素原子的甾体的生物活性和结构多样性。
Molecules. 2023 Jul 20;28(14):5549. doi: 10.3390/molecules28145549.
7
Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia.维生素 D 治疗可预防尿毒症引起的主动脉 microRNA-145 减少,尽管存在高磷血症,但仍能减轻成骨分化。
Nutrients. 2022 Jun 22;14(13):2589. doi: 10.3390/nu14132589.
8
Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease.在慢性肾脏病中发生认知障碍和其他神经紊乱的情况下的磷酸盐。
Int J Mol Sci. 2022 Jul 1;23(13):7362. doi: 10.3390/ijms23137362.
9
Hydrogen phosphate selectively induces MDA MB 231 triple negative breast cancer cell death in vitro.氢磷酸盐选择性诱导 MDA-MB-231 三阴性乳腺癌细胞体外死亡。
Sci Rep. 2022 Mar 29;12(1):5333. doi: 10.1038/s41598-022-09299-2.
10
Phosphate and Endothelial Function: How Sensing of Elevated Inorganic Phosphate Concentration Generates Signals in Endothelial Cells.磷酸盐与内皮功能:细胞如何感知无机磷酸盐浓度变化并产生信号。
Adv Exp Med Biol. 2022;1362:85-98. doi: 10.1007/978-3-030-91623-7_9.